Dr. Dennis Bourdette
I've won the following awards
John Whitaker Memorial Lecturer, VA MS Centers of Excellence
Top Doctors, Portland Monthly Magazine
Distinguished Alumnus Award, University of California, Davis
Elected to Fellow status, American Academy of Neurology
Elected to membership, American Neurological Association
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Autoimmune Dis., 2012:954739 (2012)
Cognitive impairment and MS: searching for effective therapies.
Curr Neurol Neurosci Rep., Oct;11(5):451-4 (2011)
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Ann. Neurol., Sep;70(3):362-73 (2011)
Audiometric hearing status of individuals with and without multiple sclerosis.
J Rehabil Res Dev., 47(7):669-78 (2010)
Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms.
J. Nutr. Biochem., Jul;22(7):681-90 (2011)
Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.
PLoS ONE., 5(9) (2010)
NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.
Neurology., May;74(18):1473-5 (2010)
Clinical trial of a formal group fatigue program in multiple sclerosis.
Mult. Scler., Jun;16(6):724-32 (2010)
Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
Mult. Scler., Apr;16(4):387-97 (2010)
Immunomodulatory therapies in neurologic critical care.
Neurocrit Care., Feb;12(1):132-43 (2010)
Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.
J. Neuroimmunol., Aug;199(1-2):46-55 (2008)
Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS.
Endocr Metab Immune Disord Drug Targets., Jun;8(2):132-42 (2008)
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
Immunology., Jan;123(1):66-78 (2008)
Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.
Biochem. Biophys. Res. Commun., Mar;354(1):259-64 (2007)
Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis.
J. Neuroimmunol., Jan;182(1-2):32-40 (2007)
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
J. Neurochem., Sep;98(6):1817-27 (2006)
Some effects of multiple sclerosis on speech perception in noise: Preliminary findings.
J Rehabil Res Dev., 43(1):91-8 (2006 Jan-Feb)
Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous system activity.
J Rehabil Res Dev., 43(1):83-90 (2006 Jan-Feb)
Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests.
J Rehabil Res Dev., 43(1):73-82 (2006 Jan-Feb)
Exploring educational needs of multiple sclerosis care providers: Results of a care-provider survey.
J Rehabil Res Dev., 43(1):25-34 (2006 Jan-Feb)